Ask AI
ProCE Banner Series

From All Angles: Minimizing CMV in High-Risk Kidney Transplant Recipients

Learn how to individualize CMV prevention in high-risk kidney transplant recipients, including selecting optimal antivirals and designing antiviral regimens to optimize patient outcomes.

This program was approved by the WTC 2025 Scientific Committee as an independent activity held in conjunction with the World Transplant Congress 2025. This program is not sponsored or endorsed by WTC 2025.

  ACPE
  | AMA
  | ANCC
Who Should Attend

This activity is intended for transplant and infectious diseases specialists, including physicians, nurses, pharmacists, and other healthcare professionals, who care for patients at risk for CMV following kidney transplantation.

All Events

From All Angles: Minimizing CMV in High-Risk Kidney Transplant Recipients

Upcoming Events

August

05

2025

1:00 PM - 2:00 PM Pacific Time (PT)

In-personVirtual

InterContinental San Francisco, 888 Howard St, San Francisco, California 94103

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
The goal of this activity is to improve learners’ knowledge and competence for individualizing CMV prevention to optimize outcomes in kidney transplant recipients.

Target Audience
This activity is intended for transplant and infectious diseases specialists, including physicians, nurses, pharmacists, and other healthcare professionals, who care for patients at risk for CMV following kidney transplantation.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Update antiviral protocols and clinical pathways for CMV prevention in high-risk kidney transplant recipients based on the latest developments and clinical data

  • Design antiviral regimens for kidney transplant recipients at high risk for CMV disease to mitigate the impact of CMV replication on patient outcomes

  • Select antivirals for CMV prophylaxis in kidney transplant recipients to minimize the impact of antiviral toxicities on transplant clinical courses

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.0 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA4008176-0000-25-234-L01-P 

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

CME Passport

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/662be69741e7b.png

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC, in partnership with ProCE and the American Kidney Fund

Clinical Care Options, LLC

Supporters

This activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.

Merck & Co., Inc., Rahway, NJ, USA

Partners

ProCE

ProCE Banner

American Kidney Fund

ProCE Banner

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191